Splenic macrophages from the NOD mouse are defective in the ability to present antigen

Diabetes

Volumn 47, Issue 8, 1998, Pages 1212-1218

  Piganelli, Jon D ^a   Martin, Tracy ^a   Haskins, Kathryn ^a,b  

^a UNIVERSITY OF COLORADO DENVER   (United States)

^b UNIVERSITY OF COLORADO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUTATHIONE; LYSOZYME;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN PRESENTATION; ANTIGEN PRESENTING CELL; ARTICLE; CELL DESTRUCTION; CELL MATURATION; CELL PROLIFERATION; CONTROLLED STUDY; EXPERIMENTAL DIABETES MELLITUS; INSULIN DEPENDENT DIABETES MELLITUS; MACROPHAGE; MAJOR HISTOCOMPATIBILITY COMPLEX; MALE; MOUSE; NONHUMAN; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL;

EID: 0031854250     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diab.47.8.1212     Document Type: Article

References (35)

1. Sheehy MJ: HLA and insulin-dependent diabetes. Diabetes 41:123-29, 1992
2. Hattori M, Buse JB, Jackson RA, Glimcher L, Dorf ME, Minami M, Makino S, Moriwaki K, Kuzuya H, Imura H, Strauss WM, Seidman JG, Eisenbarth GS: The NOD mouse: recessive diabetogenic genes in the major histocompatibility complex. Science 231:733-735, 1986
3. Prochazka M, Loiter EH, Serreze DV, Coleman DL: Three recessive loci required for insulin-dependent diabetes in nonobese diabetic mice. Science 237:286-289, 1987
4. Wicker LS, Miller BJ, Coker LZ, McNally SE, Scott S, Mullen Y, Appel MC: Genetic control of diabetes and insulitis in the nonobese diabetic (NOD) mouse. J Exp Med 165:1639-1654, 1987
5. nod/b heterozygote. J Immunol 142:781-784, 1989
6. Livingstone A, Edwards CT, Shizuru JA, Fathnian CG: Genetic analysis of diabetes in the nonobese diabetic mouse. I. MHC and T cell receptor beta gene expression. J Immunol 146:529-534, 1991
7. Serreze DV, Leiter EH: Development of diabetogenic T cells from NOD/Lt marrow is blocked when an allo-H-2 haplotype is expressed on cells of hemopoietic origin, but not on thymic epithelium. J Immunol 147:1222-1229, 1991
8. Serreze DV, Leiter EH: Defective activation of T suppressor cell function in nonobese diabetic mice: potential relation to cytokine deficiencies. J Immunol 140:3801-3807, 1988
9. Serreze DV, Gaskins HR, Leiter EH: Defects in the differentiation and function of antigen presenting cells in NOD/Lt mice. J Immunol 150:2534-2543, 1993
10. Roth S, Droge W: Glutathione reverses the inhibition of T-cell responses by superoptimal numbers of "nonprofessional" antigen-presenting cells. Cell Immunol 155:183-194, 1994
11. Frosch S, Bonifas M, Eck H-P, Bockstette M, Droege M, Rude E, Reske-Kunz AB: The efficient bovine insulin presentation capacity of bone marrow-derived macrophages activated by granulocyte-macrophage colony-stimulating factor correlates with high level of intracellular reducing thiols. Eur J Immunol 23:1430-1434, 1993
12. Smyth MJ: Glutathione modulates activation-dependent proliferation of human peripheral blood lymphocyte populations without regulating their activated function. J Immunol 146:1921-1927, 1991
13. Collins DS, Unanue ER, Hording CV: Reduction of disulfide bonds within lysozymes is a key step in antigen processing. J Immunol 147:4054-4059, 1991
14. Mamula MJ, Craft J: The expression of self-antigenic determinants: implications for tolerance and autoimmunity. Curr Opin Immunol 6:882-886, 1994
15. Milich DR, Jones JE, McLachlan A, Houghton R, Thornton GB, Hughes JL: Distinction between immunogenicity and tolerogenicity among HBcAg T cell determinants: influence of peptide-MHC interaction. J Immunol 143:3148-3156, 1989
16. Shahinian A, Pfeffer K, Lee KP, Kundig TM, Kishihara K, Wakeham A, Kawai K, Ohaski PS, Thompson CB, Mak TW: Differential T-cell costimulatory requirements in CD28-deficient mice. Science 261:609-612, 1993
17. Green JM, Noel PJ, Sperling AI, Walunas TL, Gray GS, Bluestone JA, Thompson CB: Absence of B7-dependent response in CD-28 deficient mice. Immunity 1:501-508, 1994
18. Thompson CB: Distinct roles for the costimulatory ligands B7-1 and B7-2 in T helper cell differentiation? Cell 81:979-982, 1995
19. Shastri N: Needles in haystacks: identifying specific peptide antigens for T-cells. Curr Opin Immunol 8:271-277, 1996
20. Neefjes JJ, Momburg JJ: Cell biology of antigen presentation. Curr Opin Immunol 5:27-34, 1993
21. Allen PM, Unanue ER: Differential requirements for antigen processing by macrophages for lysozyme-specific T cell hybridomas. J Immunol 132:1077-1079, 1984
22. Serreze DV, Prochazka M, Reifsnyder PC, Bridgett MM, Leiter EH: Use of recombinant congenic and congenic strains of NOD mice to identity a new insulin-dependent diabetes resistant gene. J Exp Med 180:1553-1558, 1994
23. Prochazka M, Serreze DV, Frankel WN, Leiter EH: NOR/Lt mice: MHC-matched diabetes-resistant control strain for NOD mice. Diabetes 41:98-106, 1992
24. Tietze F: Enzymic method for quantitative determination of nanogram amounts of total and oxidized glutathione. Anal Biochem 27:502-522, 1969
25. Gmunder H, Eck H-P, Benninghoff B, Roth S, Droge W: Macrophages regulate intracellular glutathione levels of lymphocytes: evidence for an immunoregulatory role of cysteine. Cell Immunol 129:32-46, 1990
26. Gonzales AM, Socher M. Hothersall JS, McLean P: Effects of aldose reductase inhibitor (sorbinil) on integration of polyol pathway, pentose phosphate pathway, and glycolytic route in diabetic rat lens. Diabetes 35:1200-1205, 1986
27. DeMattia G, Laurenti O, Bravi C, Ghiselli A, Iuliano L, Balsano F: Effect of aldose reduction inhibition on glutathione redox status in erytlirocytes of diabetic patients. Metabolism 43:965-968, 1994
28. Trocino RA, Akazawa S, Ishibashi M, Matsumoto K, Matsuo H, Yamamoto H, Goto S, Urata V. Kondo T, Nagataki S: Significance of glutathione depletion and oxidative stress in early embryogenesis in glucose-induced rat embryo culture. Diabetes 44:992-998, 1995
29. Jensen PE: Acidification and disulfide reduction can be sufficient to allow intact proteins to bind class II MHC. J Immunol 150:3347-3356, 1993
30. Short S, Merkel B, Caffrey R, McDoy KL: Defective antigen processing corelates with a low level of intracellular glutathione. Eur J Immunol 26:3015-3020, 1996
31. Hanson MS, Cetkovic-Cvrlje M, Ramiya VK, Atkinson MA, Maclaren NK, Singh B, Elliott JF, Serreze DV, Leiter EH: Quantitative thresholds of MHC class II I-E expressed on hemopoietically derived antigen-presenting cells in transgenic NOD/Lt mice determine level of diabetes resistance and indicate mechanism of protection. J Immunol 157:1279-1287, 1996
32. Mamula MJ: The inability to process a self-peptide allows autoreactive T cells to escape tolerance. J Exp Med 177:567-571, 1993
33. Sette A, Adorini L, Colon SM, Buus S, Grey HM: Capacity of intact proteins to bind to MHC class II molecules. J Immunol 143:1265-1267, 1989
34. Viner NJ, Nelson CA, Deck B, Unanne ER: Complexes generated by the binding of free peptides to class II MHC molecules are antigenically diverse compared with those generated by intracellular processing. J Immunol 156:2365-2368, 1996
35. g7 molecules from non-obese diabetic mice are poor peptide binders. J Immunol 156:450-458, 1996